The Ohio Star reported that Ohio Governor Mike DeWine called a special press conference on Monday, November 23 alongside the Ohio Hospital Association leaders to address the state’s COVID hospitalization rise.
As reported, during the briefing doctors who lead each of Ohio’s three zones (the state is segmented into three areas) disclosed staffing shortages due to COVID quarantine orders, which had further depleted caregiving capacity already run thin by upticks in COVID hospital cases around the state.
The Star has received inquiries from readers describing their situations. One woman told the story of her husband who was alerted that he had been exposed to COVID and within days began exhibiting symptoms. When he called his doctor seeking preventative therapies, he was denied. The man was later admitted to a hospital for days, where he received therapeutic treatments that aided his recovery.
Consequently, The Star took the opportunity during Governor DeWine’s twice-weekly COVID presser on Tuesday to ask the following question:
Public affairs strategist and all-star panelist Clint Brewer joined The Tennessee Star Report with Michael Patrick Leahy – broadcast on Nashville’s Talk Radio 98.3 and 1510 WLAC weekdays from 5:00 a.m. to 8:00 a.m. – Wednesday morning on the newsmakers line.
President Donald Trump announced during a Thursday press briefing that the anti-malarial drug chloroquine was approved by the Food and Drug Administration as a possible treatment for the coronavirus.
The announcement comes the day after Breitbart News reported that the medical establishment has known about chloroquine’s effectiveness in treating the virus since at least the 2005 SARS coronavirus outbreak.
“Clinical trials are already underway for many new therapies and we’re working on scaling these to allow many more Americans to access different drugs that have shown really good promise,” President Trump said.